We Think iTeos Therapeutics (NASDAQ:ITOS) Can Afford To Drive Business Growth

[unable to retrieve full-text content]Given this risk, we thought we’d take a look at whether iTeos Therapeutics (NASDAQ:ITOS) shareholders should be worried about its cash burn. For the purpose of this article, we’ll define cash burn as …

READ  Random real estate thoughts: Strange market days and a reminder to live fully

Leave a Reply

Your email address will not be published. Required fields are marked *